Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.

The US Treasury Department said it will give rebates if the Supreme Court decides that President Trump's "reciprocal" tariffs went beyond his authority, Treasury Secretary Scott Bessent said Sunday.